ARCHIVES

FDA Authority To Remove Paclitaxel Patent Questioned.

This article is from The Cancer Letter archive.

Vol. 27 No. 06 | February 9, 2001

Download PDF Visit The Full Archive

Related Articles

Interim Analysis Suggests Paclical Can Reduce Blood Levels

August 26, 2011

Group Opposes Bill To Allow Drug Sales After Phase I.

May 26, 2006

Addendum to RAID

December 17, 1999

National Action Plan Issues RFA For Grant Supplements

April 21, 1995

Program Announcements

August 3, 2001

Case Western Wins Renewal.

October 5, 2001